tlooto
Sign up
SCIESCOPUSQ1

Chemical Biology Letters

ScienceIn Publications, India

Chemical Biology Letters is an academic journal published by ScienceIn Publications (India). Identifiers: eISSN 2347-9825. Indexed in SCIE, SCOPUS. Metrics: JIF 6.9, CiteScore 7.4, SJR 0.995, SNIP 1.82. Subject areas: CHEMISTRY, MEDICINAL. tlooto lists 80 papers from this journal.

CiteScore

7.40

Scopus citation metric

SJR

0.995

SCImago rank

SNIP

1.82

Source normalized impact

Percentage rank

-

JIF percentile rank

Journal profile

ISSN
-
eISSN
2347-9825
Abbreviation
CHEM BIOL LETT
Publisher
ScienceIn Publications
Country
India

Web of Science categories

No Web of Science category data available.

Scopus ASJC categories

1303 Biochemistry1308 Clinical Biochemistry1312 Molecular Biology2704 Biochemistry (medical)

Papers in this journal

Recent papers

  1. Cyclic-Linear Hybrid Peptides as Molecular Transporters of Chemotherapeutic agents

    2026

  2. Alzheimer’s Disease: A comprehensive analysis of risk factors, therapeutic approaches, and emerging interventions

    2026

  3. Alkaloids and Terpenoids fractions from T. cordifolia mitigate sarcopenia-induced skeletal muscle degeneration through modulation of Akt and IL-6 signaling pathways

    2026

  4. Fumonisin B1 inhibits p53-dependent apoptosis via HOXA11-AS/miR-124/DNMT axis in human hepatoma (HepG2) cells

    2026

  5. Global Cancer Etiology: Molecular Signatures, Therapeutic Disparities, and the role of Socio-economic Determinants.

    2026 · 1 citations

Most cited papers

  1. Signaling and molecular pathways implicated in oral cancer: A concise review

    2024 · 18 citations

  2. Combating Antimicrobial Resistance: A paradigm shift from general to precision medicine

    2024 · 18 citations

  3. Beyond trial and error: Leveraging advanced software for Therapeutic discovery

    2025 · 15 citations

  4. Small-molecules against Oxidative stress mediated Neurodegenerative diseases

    2023 · 11 citations

  5. Exploring Small-Molecule Inhibitors Targeting MAPK Pathway Components: Focus on ERK, MEK1, and MEK2 Kinases in Cancer Treatment

    2024 · 11 citations